Quicklinks

Pharmaceutical Health Services, Outcomes, & Policy

Program Description

Pharmaceutical Health Services, Outcomes, and Policy (PHSOP) graduate program is an interdisciplinary program leading to the Ph.D. degree.

The increasing complexity of drug utilization in the modern world creates complex problems in pharmaceutical care delivery. Practitioners and researchers need to investigate and understand how changes in the health care system will affect the structure, process and outcomes of pharmaceutical care.

Increasingly, society has been called upon to maximize health outcomes subject to some type of budget constraint, and the need to identify and select efficient health inputs is paramount. Changes in products (goods and services), access to care, freedom of choice, reimbursement policy, direct-to-consumer advertising, third party considerations and government regulation are a few examples of the issues which will impact on the delivery of pharmaceutical care.

These issues will require researchers skilled in a broad spectrum of disciplines including, but not limited to, economics, administration, finance, marketing, epidemiology, and psychology.

The objective of the graduate program in Pharmaceutical Health Services, Outcomes, and Policy is to educate students to perform meaningful independent research and to develop scholarly characteristics preparing them for professional careers in academia, research, government, institutional pharmacy, and industry. Having accomplished the academic and research requirements, students find career opportunities with universities, industry, pharmaceutical associations, local, state and national health agencies, health care delivery organizations, managed care organizations, pharmaceutical industry, state boards of pharmacy, and medical media organizations.

 

Research Opportunities in PHSOP
The faculty members involved in the PHSOP Program have made significant accomplishments in their respective areas of interest. Their ongoing projects are supported in part by grants from the private and public funding agencies, the pharmaceutical industry, and various private foundations.

The expertise of PHSOP faculty includes:

    Quality of life
    Medication Adherence
    Pharmaceutical marketing
    Pharmacoeconomics
    Pharmacoepidemiology
    Health Policy Evaluation
    Social and Behavioral Sciences

Upon entering the PHSOP graduate program, the student will be assigned a graduate faculty advisor until the student selects a major professor.

The faculty advisor will assist the student in establishing a course of study during the first academic year, which will include correcting any deficiencies, incomplete prerequisites and required graduate courses.

In addition, this mentoring relationship is intended to assist the student in selecting their particular research focus.

Masters of Science in Pharmaceutical Health Services, Outcomes, & Policy

M.S. PROGRAM OVERVIEW

Students wishing to enter this competitive program of study leading to the Master of Science degree in Pharmaceutical Health Services, Outcomes, and Policy (PHSOP), must possess either a Bachelor degree (BS or BA), a Doctor of Pharmacy degree, or related health profession degree; such as a BSN, MD, PA, or NP. While the program is open to a broad range of backgrounds, candidates with a background in pharmacy or employed in the pharmaceutical or other healthcare sectors are preferred.  Students without prior experience in the field of pharmacy or the pharmaceutical sector may obtain admission with the provision that remedial non-credit course work may be required to acquaint them with the profession and problems of pharmacy practice in the United States. The applicant must also satisfy the requirements of The University of Georgia Graduate School prior to admission to the program. preference to will go to applicants possessing either a B.S. in Pharmacy or a Pharm.D. degree, and those whom are licensed to practice pharmacy in the United States, or one of its territories; additionally, preference given to other U.S. trained health professionals such as nurses and physicians. Applicants not having these credentials could obtain admission with the provision that remedial non-credit course work may be required to acquaint them with the profession and problems of pharmacy practice in the United States. The applicant must also satisfy the requirements of The University of Georgia Graduate School prior to admission to the program.

The program of study for the M.S. degree must include: 1) at least 3 hours of thesis research, 2) a total of not less than 27 semester hours of graduate courses, excluding thesis research and writing, and 3) at least 12 of the 27 hours must be in courses open only to graduate students. In addition, students are required to take PHSOP Seminar (PHRM 8620) during all fall and spring semesters.  A Master’s degree will typically take 1-2 years to complete, however part-time students must fulfill all requirements for the Master’s degree within a 6 year time limit beginning with the first registration for graduate courses listed on the program of study.

Click Here for an Example of the MS Curriculum

 

Ph.D. Program

Follow this link to view the curriculum for PHSOP

PHSOP Program Handbook, Brochure, and Student Forms

Contact the Program Director

Recent Graduates and Dissertation Titles

Spring 2016
Samah Al-Shatnawi, Ph.D.
Alcohol Use Behaviors and Outcomes in Professional Student Pharmacists

Spring 2015
Rian Marie Extavour, Ph.D.
Prescribing of Potentially Inappropriate Psychotrophic Medications for Older, Community-Dwelling Adults

Summer 2014:

Palak Krunal Kumar Patel, Ph.D.
Prostrate Cancer Burden: Addressing Issues of Diagnosis and Development

Summer 2013:
J. Heath Ford, Ph.D., Pharm.D.
Pharmacists in Disasters

Spring 2013:
Anne Kangethe, Ph.D., Pharm.D., MPh.
Cost Benefit Analysis of a Diabetes Prevention Program in Rural Kenya

Chakita Williams, Ph.D. 
 
Applying a Model of Risk Information Seeking to a Newly Discovered Drug Risk

Fall 2011:
Ming-Yi Haung, Ph.D. 
Utilization of Conjoint Analysis to Elicit Preferences for Genetic Testing for Alzheimer's Disease